Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Summit Subsidiary Gets Approval to Test Vision System
Jul 1999
WALTHAM, Mass., July 30 -- Summit Technology Inc. reports that its Autonomous Technologies subsidiary has been granted an Investigational Device Exemption by the US Food and Drug Administration. The company will begin studying the feasibility of performing customized ablations using a combination of its patented CustomCornea measurement device and its LADARVision System. The CustomCornea technology was designed to enable surgeons to treat ocular aberrations that cannot be detected or compensated for using existing refractive systems. Summit's study will include the treatment of myopia, hyperopia, and astigmatism through such current methods as photorefractive keratectomy (PRK) and laser in-situ keratomileusis (LASIK).

News & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.